Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia.

Joana M Murad1, Luiz G Tone, Liliana R de Souza

  • 1Department of Biochemistry and Immunology, School of Medicine University of São Paulo, 14049-900 Ribeirão Preto, SP, Brazil.

Blood Cells, Molecules & Diseases
|December 21, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas.

Cancer gene therapy·2023
Same author

Indisulam Reduces Viability and Regulates Apoptotic Gene Expression in Pediatric High-Grade Glioma Cells.

Biomedicines·2023
Same author

MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways.

Journal of cellular biochemistry·2021
Same author

Caesarean sections, prenatal and postnatal conditions and childhood acute lymphoblastic leukaemia: A case-control study in the State of São Paulo, Brazil.

Cancer epidemiology·2020
Same author

Detection by a simple and cheaper methodology of Ik6 and Ik10 isoforms of the IKZF1 gene is highly associated with a poor prognosis in B-lineage paediatric acute lymphoblastic leukaemia.

British journal of haematology·2019
Same author

Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.

Cytotherapy·2018

This study reports the first detection of a mutation in the RNA-binding domain I (RBD-I) of the RNA-dependent protein kinase (PKR) gene in pediatric acute lymphoblastic leukemia (ALL) tumor cells, potentially impacting PKR

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • RNA-dependent protein kinase (PKR) is crucial for interferon-mediated antiviral activity and influences cell growth, differentiation, and apoptosis.
  • The tumor suppressor role of PKR remains controversial, with its RNA-binding domains (RBD-I and RBD-II) being critical for activation and function.
  • Mutations in PKR's RNA-binding domains have not been previously reported in patient tumor cells.

Purpose of the Study:

  • To investigate mutations in the RBD-I and RBD-II of the PKR gene in children diagnosed with acute lymphoblastic leukemia (ALL).
  • To determine if identified mutations affect PKR's RNA-binding capability and activation.
  • To explore the potential role of PKR mutations in the pathogenesis of pediatric ALL.

Main Methods:

Related Experiment Videos

  • RNA extraction from bone marrow samples of 15 pediatric ALL patients (5 T-lineage, 10 B-lineage).
  • cDNA synthesis followed by PCR amplification of PKR's RBD-I and RBD-II sequences.
  • Cloning and sequencing of PCR products to identify point mutations.

    • Main Results:

    • A single point mutation (cDNA nt 50 A --> G, resulting in 17 Tyr-->Cys) was identified in RBD-I of PKR from a T-cell lineage ALL patient.
    • Activation of the identified PKR mutant by polyinosinic acid:polycytidylic acid (poly I:C) was impaired compared to wild-type PKR.
    • This represents the first reported instance of a mutation in PKR's RBD-I within tumor cells directly obtained from patients.

    Conclusions:

    • A specific point mutation in PKR's RBD-I was detected in a pediatric T-cell ALL case.
    • The identified mutation impairs PKR activation, suggesting a potential role in leukemic cell development.
    • Further research is necessary to fully elucidate the contribution of this PKR mutation to ALL formation and progression.